- Lobbying
- Lobbying by SAGE Therapeutics
Lobbying Relationship
Bills mentioned
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
H.R.19: Lower Costs, More Cures Act of 2019
Sponsor: Greg Walden (R-Ore.)
H.R.4996: Helping MOMS Act of 2020
Sponsor: Robin Kelly (D-Ill.)
H.R.133: Consolidated Appropriations Act, 2021
Sponsor: Henry Cuellar (D-Texas)
H.R.1319: American Rescue Plan Act of 2021
Sponsor: John Yarmuth (D-Ky.)
H.R.2026: To provide for a limitation on availability of funds for Department of...
Sponsor: Andy Biggs (R-Ariz.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Darren Willcox | Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Health & Human Services - Dept of (HHS)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate